ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263105.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.004998748	Resistant
ENSG00000263105.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.040857051	Resistant